Dongyin Yu

Suppression of angiogenesis and tumor growth by selective inhibition of angiopoietin-2

Jonathan D. Oliner, Hosung Min, Juan Leal et al. · Cancer Cell · 2004 · 469 citations · Full text

Medicine, Cancer Biology, Oncology +14

Discovery of AMG 232, a Potent, Selective, and Orally Bioavailable MDM2–p53 Inhibitor in Clinical Development

Daqing Sun, Zhihong Li, Yosup Rew et al. · Journal of Medicinal Chemistry · 2014 · 296 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +7

Complementary Actions of Inhibitors of Angiopoietin-2 and VEGF on Tumor Angiogenesis and Growth

Hiroya Hashizume, Beverly L. Falcón, Takashi Kuroda et al. · Cancer Research · 2010 · 250 citations · Full text

Medicine, Oncology, Pharmacology +17

Association of p62, a Multifunctional SH2- and SH3-Domain-Binding Protein, with src Family Tyrosine Kinases, Grb2, and Phospholipase Cγ-1

Stéphane Richard, Dongyin Yu, Kendall Blumer et al. · Molecular and Cellular Biology · 1995 · 195 citations · Full text

Life Sciences, Biochemistry, Cell Biology +17

Structure-Based Design of Novel Inhibitors of the MDM2–p53 Interaction

Yosup Rew, Daqing Sun, Felix González-López de Turiso et al. · Journal of Medicinal Chemistry · 2012 · 169 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14